Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Lifton, Richard P

Class:IdPerson:6797770
_displayNameLifton, Richard P
_timestamp2015-09-16 10:26:39
created[InstanceEdit:6797849] Garapati, Phani Vijay, 2015-09-16
firstnameRichard P
initialRP
surnameLifton
(author)[LiteratureReference:6797896] Sequence variants in SLITRK1 are associated with Tourette's syndrome
[LiteratureReference:6802011] Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
[LiteratureReference:9652716] Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
[LiteratureReference:9677799] An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis
[LiteratureReference:9698138] The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities
[LiteratureReference:9755840] X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
[LiteratureReference:9843011] Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma
[LiteratureReference:9856303] ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
[LiteratureReference:9922683] CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation
[Change default viewing format]
No pathways have been reviewed or authored by Lifton, Richard P (6797770)